Clinical Trials

Clinical studies are critical to advancing scientific research and helping us evaluate the potential role of radiodiagnostics and radiotherapeutics in improving patient care. 

Understanding Clinical Trials

Clinical trials are research studies aimed at evaluating a medical, surgical, or behavioral intervention in patients. They are the primary way that researchers find out if a new treatment, diagnostic drug or medical device is safe and effective in patients.

Before a clinical trial can begin, applicable regulatory authorities may require laboratory studies to assess a potential new medicine’s safety. When these studies involve animals, they are conducted under strict ethical and animal welfare standards. Clinical trials are then conducted in accordance with applicable regulatory and ethical standards to evaluate the medicine’s safety and performance in people.

See our list of active clinical trials

Cu64 PSMA I&T

Phase 1
Phase 2
Phase 3
Phase 4
Study Title

PET Imaging in Men With Newly Diagnosed Prostate Cancer (Solar-Recur)

Clinical Trial Number

NCT06235151

Disease Area

Prostate Cancer

Status

Active, not recruiting

Cu64 PSMA I&T (SOLAR-RECUR)

Phase 1
Phase 2
Phase 3
Phase 4
Study Title

Cu64 PSMA I&T PET/CT in men with suspected biochemical recurrence of prostate cancer

Clinical Trial Number

NCT06235099

Disease Area

Prostate Cancer

Status

Completed

Lu177 PSMA I&T

Phase 1
Phase 2
Phase 3
Phase 4
Study Title

177Lu-PSMA-I&T versus Hormone Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer.

Clinical Trial Number

NCT05204927

Disease Area

Prostate Cancer

Status

Active, not recruiting

Additional information on all these trials can be found via ClinicalTrials.gov.